About the Authors

Ian Ford, Vladimir Bezlyak
Robertson Centre for Biostatistics, University of Glasgow, Glasgow, Scotland

David J Stott
Academic Section of Geriatric Medicine, Cardiovascular Division, University of Glasgow, Glasgow, Scotland

Naveed Sattar, Chris J Packard, James Shepherd
Department of Vascular Biochemistry, North Glasgow Division, Greater Glasgow Health Board, Glasgow, Scotland

Ivan Perry, Brendan M Buckley
Department of Pharmacology and Therapeutics, Cork University Hospital, Wilton, Cork, Ireland

J. Wouter Jukema
Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands

Anton J. M de Craen, Rudi G. J Westendorp
Section of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, The Netherlands

Corresponding Author

ian@stats.gla.ac.uk

Competing Interests

JS reports that he was a consultant to Pfizer in the Treating to New Targets study and that he has been a speaker's bureau member for AstraZeneca and Pfizer.

Author Contributions

IF, DJS, CJP, IP, BMB, JWJ, AJMdC, RGJW, and JS designed the study. IF, VB, NS, BMB, JWJ, RGJW, and JS analyzed the data. BMB, JWJ, RGJW, and JS enrolled patients. IF, VB, DJS, NS, CJP, IP, BMB, JWJ, AJMdC, RGJW, and JS contributed to writing the paper.